Kar Siven, Gupta Harshita, Shaikh Nusrat, Lele Vikram
Department of Nuclear Medicine and PET-CT, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India.
World J Nucl Med. 2024 Jul 24;23(4):299-301. doi: 10.1055/s-0044-1788738. eCollection 2024 Dec.
Malignancies are increasing worldwide with changing lifestyle, pollution, increasing life expectancy, and diagnostic advancements. However, multiple primary malignancies (MPMs) detected simultaneously are very rare. Here, we present a rare case of three primary malignancies (sigmoid colon, prostate, and thyroid) detected simultaneously in a 77-year-old male patient, who initially presented with bleeding per rectum and was then found to have a large pedunculated mass in the sigmoid colon on colonoscopy, which further turned out to be adenocarcinoma. On further imaging and investigations, two new separate malignancies (prostate and thyroid) were found by two different positron emission tomography radiotracers: prostate-specific membrane antigen (PSMA) and fluorodeoxyglucose (FDG). Hence, nuclear medicine modalities can play an important role in detecting MPMs using the vast array of radiotracers available now and perhaps reduce the need for multiple biopsies.
随着生活方式的改变、污染、预期寿命的延长以及诊断技术的进步,全球范围内恶性肿瘤的发病率正在上升。然而,同时检测到的多重原发性恶性肿瘤(MPM)非常罕见。在此,我们报告一例罕见病例,一名77岁男性患者同时被检测出患有三种原发性恶性肿瘤(乙状结肠、前列腺和甲状腺)。该患者最初表现为直肠出血,随后在结肠镜检查中发现乙状结肠有一个带蒂的大肿块,进一步检查发现是腺癌。在进一步的影像学检查和调查中,通过两种不同的正电子发射断层显像剂:前列腺特异性膜抗原(PSMA)和氟脱氧葡萄糖(FDG),发现了另外两种独立的恶性肿瘤(前列腺和甲状腺)。因此,核医学模式可以利用现有的大量放射性示踪剂在检测MPM中发挥重要作用,并且可能减少多次活检的必要性。